Br J Oral Maxillofac Surg 2008, 46: 1–5 CrossRefPubMed 21 de Agu

Br J Oral Maxillofac Surg 2008, 46: 1–5.CrossRefPubMed 21. de Aguiar AF Jr, Kowalski LP, de Almeida OP: Clinicopathological and immunohistochemical evaluation Everolimus solubility dmso of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncol 2007, 43: 593–601.CrossRefPubMed 22. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K: Systematic

discovery of regulatory motifs in human promoters and 3′UTRs by comparison of several mammals. Nature 2005, 434: 338–345.CrossRefPubMed 23. Watanabe T, Takeda A, Mise K, Okuno T, Suzuki T, Minami N: Stage-specific expression of microRNAs during Xenopus development. FEBS Lett 2005, 579: 318–324.CrossRefPubMed 24. Thomson JM, Parker J, Perou CM, Hammond SM: A custom microarray platform for analysis of microRNA gene expression. Nat Methods 2004, 1: 47–53.CrossRefPubMed

25. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. PNAS 2001, 98: 5116–5121.CrossRefPubMed beta-catenin inhibitor 26. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. PNAS 1998, 95: 14863–14868.CrossRefPubMed 27. Schmittgen TD, Jiang J, Liu Q, Yang L: A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Research 2004, 32: e43.CrossRefPubMed 28. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006, 24: 1151–1161.CrossRefPubMed 29. Salley JJ: Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res 1954, 33: 253–262.CrossRefPubMed 30. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli selleck products N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell’Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic

leukemias. PNAS 2004, 101: 11755–11760.CrossRefPubMed 31. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES, Hager J, Tikhonova IR, Walker SJ, Zhang L, Hurban P, de Longueville F, Fuscoe JC, Tong W, Shi L, Wolfinger RD: Performance comparison of one-color and twocolor platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol 2006, 24: 1140–1150.CrossRefPubMed 32. Luo MY, Tian ZG, Xu Z: Construction and application of a microarray for profiling microRNA expression. Prog Biochem Biophys 2007, 34: 31–41. 33. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005, 435: 834–838.CrossRefPubMed 34. Tong AW, Nemunaitis J: Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 2008, 15: 341–355.CrossRefPubMed 35.

This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>